The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,317.00
Bid: 1,317.50
Ask: 1,318.50
Change: -17.50 (-1.31%)
Spread: 1.00 (0.076%)
Open: 1,342.50
High: 1,342.50
Low: 1,316.50
Prev. Close: 1,334.50
PSN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

27 Apr 2017 07:00

RNS Number : 4679D
Persimmon PLC
27 April 2017
 

 

TRADING UPDATE

 

THURSDAY 27 APRIL 2017

 

Persimmon plc ("the Company") will hold its Annual General Meeting ("AGM") at 12.00 noon today at York Racecourse when the Chairman will make the following statement regarding current trading, financial performance and the outlook for the current financial year. This statement covers the period from 1 January 2017 to date and supplements the update given in the announcement of the 2016 Final Results on 27 February 2017.

 

Persimmon's operational performance continues to be excellent, with the Group delivering higher volumes of newly built homes in local communities across all our regional markets, supported by the resilience of the UK economy. The prevailing disciplined approach to mortgage lending is enabling customers to buy newly built homes on attractive but sustainable terms. Our focus on building family housing at affordable prices provides a compelling choice for potential new home buyers and has attracted 6% more visitors to our development sites than last year at this stage.

 

Total forward sales revenue, including legal completions taken to date in 2017, is currently £2.56 billion, c.11% higher than last year (2016: £2.31 billion). As expected, despite the particularly strong comparatives from the first quarter of last year, our weekly private sales rate per site since reporting our 2016 Final Results on 27 February 2017 is 12% ahead of last year, resulting in a sales rate which is now 4% ahead for the year to date. We have 8,928 new homes sold forward into the private ownership market with an average selling price of c. £229,500, an increase of 4.1% over the prior year.

 

Despite the continued difficulties encountered with planning delays, we have opened 67 of the 90 new sites planned for the first half of the year. These new sales outlets opened across the UK continue to support our margin progression, due to the associated lower land cost recoveries, which has been aided further by some modest price improvement through the Spring period so far. The Group is currently developing 382 active sales outlets across the UK and is building new homes on all sites that have an implementable detailed planning consent. During the period we continued to identify good opportunities to acquire new land to support the future growth of the business.

 

The Directors are pleased to announce that the Company has recently concluded a one year extension of the maturity date of its £300m Revolving Credit Facility, out to 31 March 2022, with the Company's five relationship banks.

 

Exercising capital discipline through the cycle whilst growing the business as market conditions allow are key features of the Group's strategy launched in early 2012. Our Capital Return Plan to return surplus capital to shareholders over the ten year period to 2021 continues to be a fundamental element of this capital discipline.

 

As announced on 27 February 2017, an additional payment under the Capital Return Plan of 25p per share, or £77 million, was paid to shareholders as a dividend on 31 March 2017. At the same time the Board confirmed that the scheduled return of 110p per share, or £338 million, will be paid to shareholders on 3 July 2017 also as a dividend. These payments will bring the total value of surplus capital returned to shareholders at that date to £1,488 million, or £4.85 per share. This total is £629 million greater than that originally planned at launch in 2012.

 

The successful trading performance of Persimmon has enabled the Board to increase the value of the original Capital Return Plan by 49%, or c. £937 million. The total value of the Capital Return Plan is now c. £2.85 billion, or £9.25 per share.

 

The acceleration and significant uplift in the value of the Capital Return Plan has been facilitated by the Group increasing the volume of its legal completions of newly built homes substantially since 2012. The Group has sold over 70,000 new homes since the launch of the plan, in part by opening five new operating businesses, and by opening over 1,000 new sales outlets whilst investing over £2.5 billion in new land. In total the Group has generated £1.96 billion of free cash before the return of surplus capital over the five years since the launch of the Group's strategy in 2012.

 

The Board remains confident of the future prospects of the Group.

 

We will provide a further report in our Trading Update on Wednesday 5 July 2017.

 

 

 

For further information please contact:

 

Jeff Fairburn, Group Chief Executive

Simon Rigby

Mike Killoran, Group Finance Director

Kevin Smith

Persimmon plc

Jos Bieneman

Tel: +44 (0) 20 7638 9571 on the day

Citigate Dewe Rogerson

Tel: +44 (0) 1904 642199 thereafter

Tel: +44 (0) 20 7638 9571

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTDMGZDVVVGNZM
Date   Source Headline
2nd Apr 20241:49 pmRNSTotal Voting Rights
28th Mar 202412:53 pmRNSDirector/PDMR Shareholding
25th Mar 20244:47 pmRNSDirector/PDMR Shareholding
25th Mar 20242:07 pmRNSAnnual Report 2023 and Notice of AGM 2024
12th Mar 20241:38 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSFull Year Results
11th Jan 20246:00 pmRNSDechra Pharmaceuticals
10th Jan 20247:00 amRNSTrading Statement
1st Dec 20234:48 pmRNSBlock listing Interim Review
1st Dec 20234:45 pmRNSTotal Voting Rights
17th Nov 202310:25 amRNSHolding(s) in Company
8th Nov 20237:00 amRNSAppointment of Chief Financial Officer
7th Nov 20237:00 amRNSQ3 Trading Statement
3rd Nov 20231:15 pmRNSHolding(s) in Company
1st Sep 20231:15 pmRNSTotal Voting Rights
10th Aug 20237:04 amRNSHalf Year Results
27th Jul 202310:13 amRNSDirectorate Change
10th Jul 20239:27 amRNSDirector Declaration
3rd Jul 20232:46 pmRNSTotal Voting Rights
1st Jun 20234:38 pmRNSTR-1: Notification of major holdings
1st Jun 20231:07 pmRNSBlock listing Interim Review
1st Jun 202311:06 amRNSTotal Voting Rights
3rd May 20235:00 pmRNSHolding(s) in Company
3rd May 20234:12 pmRNSDirector/PDMR Shareholding
2nd May 202311:13 amRNSTotal Voting Rights
26th Apr 20234:32 pmRNSResult of AGM
26th Apr 20237:00 amRNSQ1 Trading Statement
3rd Apr 20234:01 pmRNSDirector/PDMR Shareholding
3rd Apr 20233:05 pmRNSTotal Voting Rights
27th Mar 20233:44 pmRNSDirector/PDMR Shareholding
22nd Mar 20233:00 pmRNSAnnual Report 2022 and Notice of AGM 2023
13th Mar 20231:57 pmRNSDirectorate Change
13th Mar 202312:19 pmRNSUK Government Self Remediation Contract Signed
7th Mar 20235:33 pmRNSHolding(s) in Company
7th Mar 20237:04 amRNSDirector Declaration
6th Mar 20235:02 pmRNSHolding(s) in Company
1st Mar 20237:00 amRNSFull Year Results
12th Jan 20237:00 amRNSTrading Statement
1st Dec 20225:30 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Dec 20225:25 pmRNSVoting Rights and Capital
8th Nov 20227:00 amRNSTrading Statement
1st Nov 20221:00 pmRNSTotal Voting Rights
1st Nov 20229:24 amRNSHolding(s) in Company
10th Oct 20222:24 pmRNSDirector/PDMR Shareholding
5th Oct 202210:26 amRNSHolding(s) in Company
4th Oct 20223:07 pmRNSDirector/PDMR Shareholding
3rd Oct 20222:12 pmRNSTotal Voting Rights
22nd Sep 20223:54 pmRNSDirector/PDMR Shareholding
17th Aug 20227:00 amRNSHalf Year Results
1st Aug 20222:30 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.